Skip to main content
Veterinary Medicines

HATCHPAK IB H120

Authorised
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live

Product identification

Medicine name:
HATCHPAK IB H120
HATCHPAK IB H120, užšaldyta suspensija purškiamai suspensijai
Active substance:
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
Target species:
  • Chicken (one day-old chick)
Route of administration:
  • Oculonasal use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
    3.70
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Concentrate for nebuliser solution
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken (one day-old chick)
      • All relevant tissues
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD07
Authorisation status:
  • Valid
Authorised in:
This information is not available for this product.
Package description:
  • Container of liquid nitrogen of canisters of 4 yellow ampoules of 15,000 doses
  • Container of liquid nitrogen of canisters of 4 yellow ampoules of 10,000 doses

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/07/1774/001-002
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0171/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Romania
  • Slovakia
  • Slovenia
  • United Kingdom (Northern Ireland)

Documents

RV1774.pdf

Lithuanian (PDF)
Published on: 24/05/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."